Immune stromal components impede biological effectiveness of carbon ion therapy in a preclinical model of pancreatic ductal adenocarcinoma
Katy L. Swancutt, Eslam A. Elghonaimy, James H. Nicholson, Laurentiu M. Pop, Brock J. Sishc, Elizabeth M. Alves, Cassandra Hamilton, Adam Rusek, Anthony J. Davis, Raquibul Hannan, Michael D. Story, Todd Anthony Aguilera
This study evaluates carbon ion therapy's effectiveness in pancreatic ductal adenocarcinoma, finding that immune stromal components reduce its efficacy in vivo compared to in vitro results.
Molecular Cancer Therapeutics · Oct 13, 2025Peer-reviewedCancer Biology